Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Effects of GLP-1 Receptor Activation
NCT03101930Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2017
- Primary completion
- Jun 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity, prediabetes, sponsored by Vanderbilt University Medical Center. Started May 2017; status: completed.
02
Drugs
03
Conditions
obesityprediabetes
Beyond the preview
Go deeper on NCT03101930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03101930.